MTOR and Hyperglycemia: Nonetheless, our data collectively illustrate that direct inhibition of mTOR in the upper small intestine is sufficient to lower glucose production and plasma glucose levels in rodents with HFD-induced insulin resistance as well as hyperglycemia, and is necessary for the glucose-lowering effect of metformin.